Associations between matrix metalloproteinase gene polymorphisms and the development of cerebral infarction

Genetics and Molecular Research

Volumn 14, Issue 4, 2015, Pages 19418-19424

  Zhao, J H ^a,b   Xu, Y M ^a   Xing, H X ^b   Su, L L ^b   Tao, S B ^b   Tian, X J ^b   Yan, H Q ^b   Ji, S B ^b  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b The First Affiliated Hospital of Xinxiang Medical University   (China)

Author keywords

Cerebral infarction; Matrix metalloproteinases; Polymorphism

Indexed keywords

GELATINASE B; STROMELYSIN; MMP3 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN;

ADULT; ARTICLE; BODY MASS; BRAIN INFARCTION; BRAIN ISCHEMIA; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MMP3 GENE; MMP9 GENE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CEREBRAL INFARCTION; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MIDDLE AGED; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84955484270     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.December.30.3     Document Type: Article

References (16)

1. Ahluwalia TS, Khullar M, Ahuja M, Kohli HS, et al. (2009). Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians. PLoS One 4: e5168.
2. Chen Q, Jin M, Yang F, Zhu J, et al (2013). Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. Mediators Inflamm. 2013: 928315.
3. Fatar M, Stroick M, Steffens M, Senn E, et al. (2008). Single-nucleotide polymorphisms of MMP-2 gene in stroke subtypes. Cerebrovasc. Dis. 2008: 26: 113-119.
4. Galis ZS and Khatri JJ (2002). Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res. 90: 251-262.
5. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, et al. (2011). Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42: 517-584.
6. Kaplan RC, Smith NL, Zucker S, Heckbert SR, et al. (2008). Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke. Atherosclerosis 201: 130-137.
7. Katakami N, Takahara M, Kaneto H, Shimizu I, et al (2010). Accumulation of gene polymorphisms related to plaque disruption and thrombosis is associated with cerebral infarction in subjects with type 2 diabetes. Diabetes Care 33: 390-395.
8. Li J, Lu H, Tao F, Zhou H, et al. (2013). Meta-analysis of MMP9-562C/T and the risk of coronary heart disease. Cardiology 124: 53-59.
9. Manso H, Krug T, Sobral J, Albergaria I, et al. (2010). Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke. BMC Med. Genet. 11: 40.
10. Moniche F, Montaner J, Gonzalez-Marcos JR, Carmona M, et al. (2014). Intra-arterial bone marrow mononuclear cell transplantation correlates with GM-CSF, PDGF-BB, and MMP-2 serum levels in stroke patients: results from a clinical trial. Cell Transplant. 1: S57-S64.
11. Montaner J, Fernandez-Cadenas I, Molina CA, Monasterio J, et al. (2003). Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene. Stroke 34: 2851-2855.
12. Nie SW, Wang XF and Tang ZC (2014). Correlations between MMP-2/MMP-9 promoter polymorphisms and ischemic stroke. Int. J. Clin. Exp. Med. 7: 400-404.
13. Siefert SA and Sarkar R (2012). Matrix metalloproteinases in vascular physiology and disease. Vascular 20: 210-216.
14. Szczudlik P and Borratynska A (2010). Association between the -1562 C/T MMP-9 polymorphism and cerebrovascular disease in a Polish population. Neurol. Neurochir. Pol. 44: 350-357.
15. Wang L, Ma YT, Xie X, Yang YN, et al. (2011). Association of MMP9 gene -1562 C/T polymorphism with myocardial infarction in Uighur population of Xinjiang. Zhonghua YiXue Yi Chuan Xue Za Zhi 28: 180-184.
16. Zhang X, Cao X, Xu X, Li A, et al. (2015). Correlation between the -1562C/T polymorphism in the matrix metalloproteinase-9 gene and hemorrhagic transformation of ischemic stroke. Exp. Ther. Med. 9: 1043-1047.